Strain Name: |
B6;129-Ly9tm1Mckn/J |
|---|---|
Stock Number: |
006011 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Former Name |
B6.129-Ly9tm1Mckn/J (Changed: 19-FEB-07
) |
| Genes & Alleles | Ly9; Ly9tm1Mckn; |
Type JAX® GEMM® Strain - Mutant Stock Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Targeted Mutation Species laboratory mouse Donating Investigator David McKean, Mayo Clinic Generation N2pN1 Strain Description
Mice homozygous for the targeted mutation are viable, fertile, and do not display any gross anatomical or behavioral abnormalities. FACS analysis of splenocytes confirms homozygous mice do not express the endogenous protein. When stimulated with anti -CD3, splenocytes cultured from homozygous mice show significant early T cell activation defects (proliferation and IL-2 production). When stimulated with anti-TCR and anti-CD28, CD4+ T splenocytes cultured from homozygous mice exhibit mild defects in Th2 cytokine production, but respond normally to cytokine stimulation. These mutant mice may be useful in studies of innate and adaptive immunity, lymphocyte signaling/costimulation, T cell activation, Th1/Th2 cytokine function, and CD2/SLAM family signal transduction.Strain Development
A targeting vector was designed to replace the 3' portion of exon 2 of the endogenous gene with a neomycin resistance gene. The construct was injected into 129/SvEES embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts and next implanted into pseudopregnant surrogate mothers. Chimeric mice were subsequently bred with C57BL/6 mice for one generation before arrival at The Jackson Laboratory. Upon arrival, mutant mice were backcrossed to C57BL/6J for approximately 2 generations.
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Ly9tm1Mckn | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, David J McKean | ||
| Mutation Made By | David McKean, Mayo Clinic | ||
| Strain of Origin | 129/Sv | ||
| ES Cell Line Strain | 129 | ||
| Gene Symbol and Name | Ly9, lymphocyte antigen 9 | ||
| Chromosome | 1 | ||
| Gene Common Name(s) | AI893573; CD229; Lgp100; Ly-9; SLAMF3; T100; expressed sequence AI893573; hly9; mLY9; | ||
| General Note | Despite a significant defect in early T cell activation and a slight but significant defect in the Th2 response of CD4+ T cells, homozygous mutant mice mount appropriate T and B cell responses to lymphocytic choriomeningitis virus, their NKT cell development is normal, and mutant macrophages exhibit no defects in cytokine production or bacterial killing. | ||
| Molecular Note | A 3' part of exon 2 and all of intron 2 have been replaced by a neomycin resistance gene. Western blot analysis of thymocytes and FACS analysis of splenocytes from homozygous mutant mice using rabbit antisera against the extracellular domain detected no LY9 (CD229) protein on these cells. [MGI Ref ID J:105482] | ||
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Ly9tm1Mckn
| Breeding & Husbandry | When maintaining a live colony, these mice are bred as homozygotes. |
|---|
Congenic Nomenclature
Cell Biology Research
Signal Transduction
Transcriptional Regulation
Immunology and Inflammation Research
Growth Factors/Receptors/Cytokines
Immunodeficiency (T cell deficiency)
Internal/Organ Research
Lymphoid Tissue Defects (T cell deficiency)
Research Tools
Immunology and Inflammation Research (T cell deficiency)
Immunology and Inflammation Research (T cell specific surface marker)
Selected Reference(s)
Graham DB; Bell MP; McCausland MM; Huntoon CJ; van Deursen J; Faubion WA; Crotty S; KcKean DJ. 2006. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice J Immunol 176(1):291-300. [PubMed: 16365421] [MGI Ref ID J:105482]
| Strain Name: | B6;129-Ly9tm1Mckn/J |
| Stock Number: | 006011 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form